Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma
Condition(s):Melanoma (Skin)Last Updated:June 22, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Melanoma (Skin)Last Updated:June 22, 2012Completed
Condition(s):Intraocular Melanoma; Melanoma (Skin)Last Updated:June 20, 2013Completed
Condition(s):Melanoma (Skin)Last Updated:June 19, 2013Completed
Condition(s):Melanoma (Skin); Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:June 19, 2013Completed
Condition(s):Melanoma (Skin)Last Updated:June 19, 2013Completed
Condition(s):Melanoma (Skin)Last Updated:June 20, 2013Completed
Condition(s):Melanoma (Skin)Last Updated:June 26, 2013Completed
Condition(s):Recurrent Melanoma; Stage IV MelanomaLast Updated:January 25, 2013Completed
Condition(s):Ciliary Body and Choroid Melanoma, Medium/Large Size; Ciliary Body and Choroid Melanoma, Small Size; Extraocular Extension Melanoma; Iris Melanoma; Metastatic Intraocular Melanoma; Mucosal Melanoma; Recurrent Intraocular Melanoma; Recurrent Melanoma; Stage IIC Melanoma; Stage IIIA Intraocular Melanoma; Stage IIIA Melanoma; Stage IIIB Intraocular Melanoma; Stage IIIB Melanoma; Stage IIIC Intraocular Melanoma; Stage IIIC Melanoma; Stage IV Intraocular Melanoma; Stage IV MelanomaLast Updated:May 22, 2014Completed
Condition(s):Intraocular Melanoma; Melanoma (Skin)Last Updated:November 20, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.